The Calgary Retina Consultants have conducted numerous multicenter clinical trials, including:

• Protein Kinase C Beta Inhibitor Studies (Diabetic Retinopathy)

• Sandostatin LAR Study (in NPDR/PDR)

• EyeTech Study (Anti-VEGF Aptomer for AMD 1004/1012)

• Allergan Posurdex RVO (Retinal Vein Occlusion)

• VIO Study (Verteporfin in Occult AMD)

• VAM Study (Verteporfin in AMD)

• Retinal Study (Verteporfin and Kenalog in AMD)

• Allergan Posurdex DME (Diabetic Study)